Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Amots who wrote (17764)	1/14/1999 12:53:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

Amots, Point well taken but I think the insider buying/selling scenario doesn't apply. Why? 1)There are very few insiders left in this company since the drastic reduction in management head count--we lost over 1/2 of the vice presidents employed from back Vivus was doing its own marketing of MUSE. 2)The 2 biggest remaining insiders of the company ie L.Wilson and V.Place already own most of the insider shares. At my last count, Place owned a total of 887,103 shares and Wilson held 479,662 shares. 3)Of the 4 remaining vice presidents the share count was as follows last time I checked: Neil Gesundheit 47,911 shares Terry Nida 5,052 shares William Smith 2,893 shares Carol Karp (?? but probably close to zero) 4)During the black out period (30 days before earnings), insiders can not buy/sell stocks. The only other insider that I know of that owns Vivus shares worth mentioning is Clair Satter with 86,573. I don't know of any other insider who owns more than 5,000 shares.